LINKIT LINKIT LINKIT OSLIN LINCOMYCIN LINCOMYCIN OLINC OLINC OLINC OLINC OLINC OLINC LIOMYN XINCOMIN LINCOLIDE LINCOLIDE DDS LINCOMYCIN LINCOTIC LINCOTIC LINCOTIC LINCOTIC LINCOTIC LINCOTIC LIMERA LIMERA IRZALINE LOCOMIN LINKOWIN LINKOWIN LINCOMED LINCOCIN LINCOCIN LINCOCIN LINCOCIN HFC NOVELINK PLIMYCINE ROLINCO OMICIN OMICIN OMICIN OMICIN LINCOMYCIN LINCOMYCIN LINCOZAF VIOCIN VIOCIN LINCOMYCIN LINCOMYCIN AMLIN AMLIN ENCONMYCIN P-STAPH P-STAPH LOLIN LINCOMYCIN FLACIN LINCOMYCIN LINCOMOX MB-LINCO MB-LINCO MB-LINCO LINCO PLUS MYLINE LINZEE LINCOBECT LINCOBECT LINCOBECT LINCOMYCIN LINCOMYCIN LINKRED LINCOMYCIN LOMIVAC LINCOCEENA LINCOCEENA LINCOCEENA IBUCIN MINCOMYCIN MINCOMYCIN MINCOMYCIN MINCOMYCIN MINCOMYCIN MINCOMYCIN LINCOM LINCOLIVE BACTO-LINK MEDILINC LINCOTIN LINCOMYCIN LINCOMYCIN LINCOREX LINCOSOFT QINROX QINROX LINCO MYLINO LINCIN LINCOGRAY LIGON LINCOMATE LINCOMATE LINCMY LINCOBIOTIC LINCOBIOTIC LINO LINO LINCOT L-SAF LINCOL LINCOPHAR MYLINCO LINCO-T

Dose: 600 mg
Single Dose: 600 (600)
Frequency: 24 hourly
Route: IM
Instructions: Frequency may be increased upto twice daily if needed.

Dose: 10 mg/kg
Single Dose: 10 (10)
Frequency: As recommended.
Route: Intra Muscular
Instructions: Once in 24 Hours

Dose: 10 to 0 mg/kg
Single Dose: 5 (5)
Frequency: As recommended.
Route: Intra Muscular
Instructions: In divided doses.

Lincomycin is the derivative of Lincomycin (HCl). It is of Semi Synthetic origin and belongs to Glactoride. It belongs to Antibacterial (Proetin synthesis inhibitor) pharmacological group on the basis of mechanism of action and also classified in Antibiotics pharmacological group.The Molecular Weight of Lincomycin (HCl) is 461.00. It is weakly acidic drug, 6.60% solution of the drug is isotonic and Its pKa is 7.6.

Lincomycin (HCl) is contraindicated in conditions like Hypersensitivity.

The severe or irreversible adverse effects of Lincomycin (HCl), which give rise to further complications include Pseudomembranous colitis, Thrombocytopenia, Angioneurotic edema, Serum sickness, Granulocytopenia, Leucopenia, Neutropenia, Erythema multiforme, Glossitis, Elevated transaminases, Apnea, Vaginitis.Lincomycin (HCl) produces potentially life-threatening effects which include Syncope, Hypotension, Anaphylaxis. which are responsible for the discontinuation of Lincomycin (HCl) therapy.The symptomatic adverse reactions produced by Lincomycin (HCl) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Nausea, Diarrhea, Fever, Tinnitus, Skin rashes, Urticaria, VertigoX, StomatitisX, Esophagitis, Perianal irritation, Rectal irritation, Vaginal irritation.

Lincomycin (HCl) is primarily indicated in conditions like Anaerobic infections, Chronic middle ear infection, Colitis, Impetigo, Osteomyelitis, Pneumonia.

Lincomycin (HCl) is known to interact with other drugs, the details of drug interactions is as follows:DrugDetailsSeverityOnsetManagementAlcuronium (Cl)Atracurium (Besylate)BamifyllineClindamycinDistigmine (Br)ErythromycinKaolinRocuronium (Br) These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Liver Function Test (LFT) Periodic blood count

Drug should not be given to Pregnant Mothers, patients suffering from Kidney dysfunction, patients suffering from Liver Malfunction, Geriatrics, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Caps Store Below 30°C. Do not Freeze. Protect from Sunlight and Moisture.

Lincomycin should be used with caution in patients with kidney or liver disease. Take appropriate measures in case of secondary infections. It should be used with caution (if contains tartrazine) in patients with aspirin hypersensitivity, because it may cause allergic reactions (including bronchial asthma).